Page last updated: 2024-11-03

propranolol and Ehlers-Danlos Syndrome

propranolol has been researched along with Ehlers-Danlos Syndrome in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Ehlers-Danlos Syndrome: A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sebastián-Ochoa, A1
Quesada-Charneco, M1
Fernández-García, D1
Reyes-García, R1
Rozas-Moreno, P1
Escobar-Jiménez, F1

Other Studies

1 other study available for propranolol and Ehlers-Danlos Syndrome

ArticleYear
Dramatic response to cholestyramine in a patient with Graves' disease resistant to conventional therapy.
    Thyroid : official journal of the American Thyroid Association, 2008, Volume: 18, Issue:10

    Topics: Adult; Antithyroid Agents; Cholestyramine Resin; Drug Resistance; Drug Therapy, Combination; Ehlers-

2008